GSE213588 8 V 3 TRAMETINIB HUMAN DN (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE213588 8 V 3 TRAMETINIB HUMAN DN.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE213588 8 V 3 TRAMETINIB HUMAN DN.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE213588 8 V 3 TRAMETINIB HUMAN DN.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE213588 8 V 3 TRAMETINIB HUMAN DN.

Results found

Linked to

 

Label

Description

 

Gene

inhibitor of DNA binding 1

Gene

DnaJ heat shock protein family (Hsp40) member A3

Gene

cytochrome P450 family 1 subfamily B member 1

Gene

cell division cycle 20

Gene

paternally expressed 10

Gene

insulin like growth factor binding protein 5

Gene

stearoyl-CoA desaturase

Gene

transforming growth factor beta induced

Gene

plasminogen activator, tissue type

Gene

transcobalamin 1

  • Gene

    inhibitor of DNA binding 1


  • Gene

    DnaJ heat shock protein family (Hsp40) member A3


  • Gene

    cytochrome P450 family 1 subfamily B member 1


  • Gene

    cell division cycle 20


  • Gene

    paternally expressed 10


  • Gene

    insulin like growth factor binding protein 5


  • Gene

    stearoyl-CoA desaturase


  • Gene

    transforming growth factor beta induced


  • Gene

    plasminogen activator, tissue type


  • Gene

    transcobalamin 1

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.